In the Mind Moments series, episode 175, Northwestern Medicine neurologists Jennifer Fokas, MD, and Minali Nigam, MD, examined present obstacles and emerging approaches for treating cluster headache. They showed the considerable disease impact, especially for individuals suffering from chronic cluster headache.
The diagnostic difficulties that arise from overlap with migraine features were also emphasized. Recognizing cranial autonomic symptoms as key distinguishing features, along with typical attack duration and circadian or seasonal patterns, is important.
Practical approaches to acute and preventive treatment were covered, including high-flow oxygen via non-rebreather mask, subcutaneous sumatriptan, bridge therapies, and preventive options such as high-dose verapamil and, in selected cases, lithium.
Read Also: New Treatments Emerge for Alzheimer’s Agitation
The physicians also reviewed emerging and adjunctive options, noting limitations in evidence, indications, and access. They concluded by emphasizing the need for clinician preparedness and tailored therapy to enable more assertive and appropriate management of cluster headache.
A study published in Headache found that cluster headache is one of the most intensely painful human conditions. The International Cluster Headache Questionnaire results showed the severity of the condition.
For those interested in learning more, episode 171 of the NeurologyLive® Mind Moments® podcast is now live, featuring an exclusive interview with Jennifer Fokas, MD, and Minali Nigam, MD, and can be accessed through various platforms, including Apple Podcasts, Spotify, and Google Podcasts, with a listen time of 21 minutes.